Hormone therapy for postmenopausal breast cancer survivors: a survey among obstetrician-gynaecologists.
Τίτλος | Hormone therapy for postmenopausal breast cancer survivors: a survey among obstetrician-gynaecologists. |
Publication Type | Journal Article |
Year of Publication | 2009 |
Authors | Vavilis, D., Zafrakas M., Goulis D. G., Pantazis K., Agorastos T., & Bontis J. N. |
Journal | Eur J Gynaecol Oncol |
Volume | 30 |
Issue | 1 |
Pagination | 82-4 |
Date Published | 2009 |
ISSN | 0392-2936 |
Λέξεις κλειδιά | Breast Neoplasms, Data Collection, Estrogen Receptor Modulators, Estrogen Replacement Therapy, Greece, Gynecology, Hot Flashes, Humans, Norpregnenes, Osteoporosis, Postmenopausal, Physician's Practice Patterns |
Abstract | PURPOSE OF INVESTIGATION: To investigate the attitude of Greek obstetrician-gynaecologists towards prescription of hormone therapy to postmenopausal breast cancer survivors.METHODS: An anonymous questionnaire was sent to members of the Hellenic Society of Obstetrics and Gynaecology with a hypothetical case and a series of relevant questions.RESULTS: Three hundred valid answers were received. Hormone therapy would be prescribed to a breast cancer survivor by only 8%; 80% of these would prefer tibolone. In contrast, 92% would not prescribe hormone therapy; 97% would do so due to the risk of disease recurrence; 70% would not prescribe any alternative therapy, 21% would prescribe CNS-active compounds and 7% SERMs.CONCLUSIONS: The vast majority of Greek obstetrician-gynaecologists would not prescribe hormone therapy for menopausal symptoms in breast cancer survivors due to the theoretical risk of disease recurrence. Among those who would not prescribe hormone therapy, 21% would opt to CNS-active compounds. |
Alternate Journal | Eur. J. Gynaecol. Oncol. |
PubMed ID | 19317264 |